This is a must read. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Detecting Cancer in 1.5 Seconds: Early Investment Opportunity](
[Learn more about how this could transform the multi-billion dollar diagnostic market.](
--------------------------------------------------------------- February 28, 2024 From the desk of the Editor Dear Reader, We have identified several stocks which are expected to go “Ex-Dividend” very soon. If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. So please keep this in mind. Below is our latest Dividend Report: --------------------------------------------------------------- Sponsor Message [Game-Changing Cancer Tech Nears FDA Completion](
the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it. [Explore Investment Opportunities in This Market Disruptor](
--------------------------------------------------------------- [Realty Income Corporation](
Symbol: [O](
Recent Price: $52.31
Average Analyst Price Target: $60.00 (14.70%)
Market Cap: $45.05B
Expected Ex-Dividend Date: Feb 29 2024
Expected Payment Date: Mar 15 2024
Expected Dividend & Yield: 5.89% Recent Analyst Action: Simon Yarmak, analyst at Stifel Nicolaus, reiterates coverage on [Realty Income Corporation (O)]( in the Real Estate sector with a Buy rating and a price target of $65 (1 week ago). [TipRanks.com]( also reports that [Realty Income Corporation]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $60.00 . The target pricing ranges from a high forecast of $65 down to a low forecast of $57. [Realty Income Corporation (O)](’s last closing price was $52.31 which would put the average price target at 14.70% upside. Here are 3rd party ratings for [O](: - TipRanks.com: Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 34% (85 out of 250)
[Click for chart >>](
-------------------------------------------------------------------------- ---------------------------------------------------------------
Sponsor Message [Rare Chance to Be an Early Investor in AI Energy Breakthrough](
expert Ian King has found a way to invest in the technology powering AI energy. A breakthrough that presents a once-in-a-lifetime opportunity for fast-acting investors. [Just go here for full details.](
--------------------------------------------------------------- [Clearway Energy, Inc.](
Symbol: [CWEN](
Recent Price: $22.35
Average Analyst Price Target: $28.20 (26.17%)
Market Cap: $4.40B
Expected Ex-Dividend Date: Feb 29 2024
Expected Payment Date: Mar 15 2024
Expected Dividend & Yield: 7.20% Recent Analyst Action: Elizabelle Pang, analyst at DBS, reiterates coverage on [Clearway Energy, Inc. (CWEN)]( in the Utilities sector with a Buy rating and a price target of $25 (1 day ago). [TipRanks.com]( also reports that [Clearway Energy, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $28.20 . The target pricing ranges from a high forecast of $37 down to a low forecast of $25. [Clearway Energy, Inc. (CWEN)](’s last closing price was $22.35 which would put the average price target at 26.17% upside. Here are 3rd party ratings for [CWEN](: - TipRanks.com: Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Sell, Bottom 34% (165 out of 250)
[Click for chart >>](
-------------------------------------------------------------------------- ---------------------------------------------------------------
Sponsor Message [Digital Dollar: Freedom or Financial Slavery?](
a digital dollar really America’s way to financial freedom? Or is it the start of a wave of financial servitude? Get the details on the potential risks of a digital dollar and what you can do to protect yourself. From privacy concerns to economic control, protect yourself with this free guide. [Escape the digital dollar with this free guide](
--------------------------------------------------------------- [Virtu Financial, Inc.](
Symbol: [VIRT](
Recent Price: $17.51
Average Analyst Price Target: $19.40 (10.79%)
Market Cap: $2.77B
Expected Ex-Dividend Date: Feb 29 2024
Expected Payment Date: Mar 15 2024
Expected Dividend & Yield: 5.48% Recent Analyst Action: Patrick Moley, analyst at Piper Sandler, reiterates coverage on [Virtu Financial, Inc. (VIRT)]( in the Financial Services sector with a Buy rating and a price target of $21 (4 weeks ago). [TipRanks.com]( also reports that [Virtu Financial, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $19.40 . The target pricing ranges from a high forecast of $21 down to a low forecast of $18. [Virtu Financial, Inc. (VIRT)](’s last closing price was $17.51 which would put the average price target at 10.79% upside. Here are 3rd party ratings for [VIRT](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Strong Sell, Bottom 42% (145 out of 250)
[Click for chart >>](
-------------------------------------------------------------------------- [Premier, Inc.](
Symbol: [PINC](
Recent Price: $21.62
Average Analyst Price Target: $25.10 (16.10%)
Market Cap: $2.59B
Expected Ex-Dividend Date: Feb 29 2024
Expected Payment Date: Mar 15 2024
Expected Dividend & Yield: 3.89% Recent Analyst Action: Jim Kelly, analyst at Leerink Partners, reiterates coverage on [Premier, Inc. (PINC)]( in the Healthcare sector with a Hold rating and a price target of $22.5 (2 days ago). [TipRanks.com]( also reports that [Premier, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $25.10 . The target pricing ranges from a high forecast of $30 down to a low forecast of $22. [Premier, Inc. (PINC)](’s last closing price was $21.62 which would put the average price target at 16.10% upside. Here are 3rd party ratings for [PINC](: - TipRanks.com: Hold
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 32% (80 out of 250)
[Click for chart >>](
-------------------------------------------------------------------------- ---------------------------------------------------------------
Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE](
for 3 Months FREE of
Bernie Schaeffer’s Option Advisor
($395 Retail Value - [FREE!]()
--------------------------------------------------------------- [PepsiCo, Inc.](
Symbol: [PEP](
Recent Price: $168.16
Average Analyst Price Target: $186.00 (10.61%)
Market Cap: $231.12B
Expected Ex-Dividend Date: Feb 29 2024
Expected Payment Date: Apr 01 2024
Expected Dividend & Yield: 3.01% Recent Analyst Action: Christopher Carey, analyst at Wells Fargo, reiterates coverage on [PepsiCo, Inc. (PEP)]( in the Consumer Defensive sector with a Hold rating and a price target of $172 (2 days ago). [TipRanks.com]( also reports that [PepsiCo, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $186.00 . The target pricing ranges from a high forecast of $200 down to a low forecast of $172. [PepsiCo, Inc. (PEP)](’s last closing price was $168.16 which would put the average price target at 10.61% upside. Here are 3rd party ratings for [PEP](: - TipRanks.com: Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Top 22% (54 out of 250)
[Click for chart >>](
-------------------------------------------------------------------------- ---------------------------------------------------------------
Sponsor Message [Don't miss your 3rd and final chance!](
You missed your chance on Pfizer... ...which soared 600% after it released Lipitor in 1997. You missed your chance on Bristol Myers... ...which soared 500% after releasing Metformin in 1994. Both of these drugs broke records and made their investors rich. But there's one opportunity you didn't miss - and Morgan Stanley predicts it will be bigger than both of these combined! [Get all the details here.](
--------------------------------------------------------------- And there you have it... Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend. If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information. Sincerely, The Editor, MarketSectorDaily.com MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer.
[If you are not a human, click here.]( This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software